Skip to main content
M

MEMPHASYS LIMITED. — Investor Relations & Filings

Ticker · MEM ISIN · AU000000MEM5 LEI · 549300RZ3LBXHF3WXL97 ASX Professional, scientific and technical activities
Filings indexed 1,180 across all filing types
Latest filing 2024-11-26 Regulatory Filings
Country AU Australia
Listing ASX MEM

About MEMPHASYS LIMITED.

https://www.memphasys.com/

Memphasys Limited is a biotechnology company specializing in the development of advanced cell separation and reproductive biotechnology solutions. The company's core technology platform utilizes proprietary membranes and electrophoresis to isolate high-quality cells from biological fluids. Its flagship product, the Felix™ system, is an automated device designed for the rapid separation of high-quality sperm from semen samples for use in human assisted reproductive technology (ART) procedures. This technology aims to improve clinical outcomes by selecting sperm with lower DNA fragmentation and higher motility compared to traditional centrifuge-based techniques. Beyond human fertility, the company applies its bio-separation expertise to animal health, including diagnostic tools for stallion fertility. Memphasys focuses on providing innovative solutions that enhance efficiency and success rates in the global reproductive health market.

Recent filings

Filing Released Lang Actions
Initial Director's Interest Notice - LE 2 pages 187.8KB
Regulatory Filings
2024-11-26 English
Final Director's Interest Notice - RC 2 pages 168.8KB
Regulatory Filings
2024-11-26 English
Address to Shareholders 2 pages 238.3KB
Regulatory Filings
2024-11-21 English
Results of Meeting 2 pages 340.4KB
Regulatory Filings
2024-11-21 English
Chair Appointment/Resignation 2 pages 189.5KB
Regulatory Filings
2024-11-20 English
Felix Clinical Trial Reaches 95% Completion 2 pages 199.2KB
Regulatory Filings
2024-11-17 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.